{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:05:47Z","timestamp":1793203547925,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12185-024-03811-2","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T14:02:21Z","timestamp":1720447341000},"page":"290-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis"],"prefix":"10.1007","volume":"120","author":[{"given":"Akash","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7643-8154","authenticated-orcid":false,"given":"Cesar","family":"Gentille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmita","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Ensor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"issue":"8","key":"3811_CR1","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1538-7836.2008.03025.x","volume":"6","author":"TE Warkentin","year":"2008","unstructured":"Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost. 2008;6(8):1304\u201312.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"3811_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.tmrv.2006.05.001","volume":"20","author":"TE Warkentin","year":"2006","unstructured":"Warkentin TE, Sheppard JAI. Testing for heparin-induced thrombocytopenia antibodies. Transfus Med Rev. 2006;20(4):259\u201372.","journal-title":"Transfus Med Rev"},{"issue":"12","key":"3811_CR3","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1111\/j.1538-7836.2004.01039.x","volume":"2","author":"JI Zwicker","year":"2004","unstructured":"Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost. 2004;2(12):2133\u20137.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"3811_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0002-9343(99)00124-2","volume":"106","author":"DE Wallis","year":"1999","unstructured":"Wallis DE, Workman DL, Lewis BE, Steen L, Pifarre R, Moran JF. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med. 1999;106(6):629\u201335.","journal-title":"Am J Med"},{"issue":"2","key":"3811_CR5","doi-asserted-by":"publisher","first-page":"21S","DOI":"10.1378\/chest.127.2_suppl.21S","volume":"127","author":"L Rice","year":"2005","unstructured":"Rice L. Cases of heparin-induced thrombocytopenia elucidate the syndrome. Chest. 2005;127(2):21S-26S.","journal-title":"Chest"},{"issue":"1","key":"3811_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1067\/mlc.2001.115525","volume":"138","author":"GP Visentin","year":"2001","unstructured":"Visentin GP, Moghaddam M, Beery SE, McFarland JG, Aster RH. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia\/thrombosis. J Lab Clin Med. 2001;138(1):22\u201331.","journal-title":"J Lab Clin Med"},{"issue":"4","key":"3811_CR7","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1046\/j.0007-1048.2002.03363.x","volume":"116","author":"P Eichler","year":"2002","unstructured":"Eichler P, Raschke R, Lubenow N, Meyer O, Schwind P, Greinacher A. The new ID-heparin\/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays: ID-heparin\/PF4 antibody test for detection of HIT antibodies. Br J Haematol. 2002;116(4):887\u201391.","journal-title":"Br J Haematol"},{"issue":"08","key":"3811_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1160\/TH10-01-0002","volume":"104","author":"C Legnani","year":"2010","unstructured":"Legnani C, Cini M, Pili C, Boggian O, Frascaro M, Palareti G. Evaluation of a new automated panel of assays for the detection of anti-PF4\/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia. Thromb Haemost. 2010;104(08):402\u20139.","journal-title":"Thromb Haemost"},{"issue":"5","key":"3811_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1600-0609.2005.00621.x","volume":"76","author":"D Juhl","year":"2006","unstructured":"Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A. Incidence and clinical significance of anti-PF4\/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Eur J Haematol. 2006;76(5):420\u20136.","journal-title":"Eur J Haematol"},{"issue":"03","key":"3811_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1055\/s-2004-831049","volume":"30","author":"J Francis","year":"2004","unstructured":"Francis J. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex. Semin Thromb Hemost. 2004;30(03):359\u201368.","journal-title":"Semin Thromb Hemost"},{"issue":"23","key":"3811_CR11","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1182\/blood.V126.23.764.764","volume":"126","author":"A Padmanabhan","year":"2015","unstructured":"Padmanabhan A, Jones C, Curtis BR, Bougie DW, Sullivan M, Peswani N, et al. A novel PF4-dependent platelet activation assay identifies patients likely to have heparin-induced thrombocytopenia\/thrombosis (HIT). Blood. 2015;126(23):764\u2013764.","journal-title":"Blood"},{"issue":"4","key":"3811_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3390\/jcm10040683","volume":"10","author":"M Marchetti","year":"2021","unstructured":"Marchetti M, Zermatten MG, Bertaggia Calderara D, Aliotta A, Alberio L. Heparin-induced thrombocytopenia: a review of new concepts in pathogenesis, diagnosis, and management. J Clin Med. 2021;10(4):683.","journal-title":"J Clin Med"},{"issue":"3","key":"3811_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMcp1411910","volume":"373","author":"A Greinacher","year":"2015","unstructured":"Greinacher A. Heparin-induced thrombocytopenia. Solomon CG, editor. N Engl J Med. 2015;373(3):252\u201361.","journal-title":"N Engl J Med"},{"issue":"3","key":"3811_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1182\/blood-2016-01-635003","volume":"128","author":"TE Warkentin","year":"2016","unstructured":"Warkentin TE, Anderson JAM. How I treat patients with a history of heparin-induced thrombocytopenia. Blood. 2016;128(3):348\u201359.","journal-title":"Blood"},{"issue":"1","key":"3811_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev.med.042808.171814","volume":"61","author":"GM Arepally","year":"2010","unstructured":"Arepally GM, Ortel TL. Heparin-induced thrombocytopenia. Annu Rev Med. 2010;61(1):77\u201390.","journal-title":"Annu Rev Med"},{"issue":"10","key":"3811_CR16","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1182\/blood-2011-11-376293","volume":"119","author":"A Cuker","year":"2012","unstructured":"Cuker A, Cines DB. How I treat heparin-induced thrombocytopenia. Blood. 2012;119(10):2209\u201318.","journal-title":"Blood"},{"issue":"3","key":"3811_CR17","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1378\/chest.125.3.856","volume":"125","author":"N Thorevska","year":"2004","unstructured":"Thorevska N, Amoateng-Adjepong Y, Sabahi R, Schiopescu I, Salloum A, Muralidharan V, et al. Anticoagulation in hospitalized patients with renal insufficiency. Chest. 2004;125(3):856\u201363.","journal-title":"Chest"},{"issue":"5","key":"3811_CR18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ckj\/sfu080","volume":"7","author":"S Hughes","year":"2014","unstructured":"Hughes S, Szeki I, Nash MJ, Thachil J. Anticoagulation in chronic kidney disease patients\u2014the practical aspects. Clin Kidney J. 2014;7(5):442\u20139.","journal-title":"Clin Kidney J"},{"issue":"9","key":"3811_CR19","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1182\/blood-2017-04-778993","volume":"130","author":"TE Warkentin","year":"2017","unstructured":"Warkentin TE, Pai M, Linkins LA. Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review. Blood. 2017;130(9):1104\u201313.","journal-title":"Blood"},{"issue":"09","key":"3811_CR20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1160\/TH14-07-0593","volume":"114","author":"B Tardy-Poncet","year":"2015","unstructured":"Tardy-Poncet B, Piot M, Montmartin A, Burdier A, Chalayer E, Tardy B. Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban. Thromb Haemost. 2015;114(09):652\u20134.","journal-title":"Thromb Haemost"},{"issue":"6","key":"3811_CR21","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/jth.13330","volume":"14","author":"LA Linkins","year":"2016","unstructured":"Linkins LA, Warkentin TE, Pai M, Shivakumar S, Manji RA, Wells PS, et al. Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study. J Thromb Haemost. 2016;14(6):1206\u201310.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"3811_CR22","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.thromres.2015.01.009","volume":"135","author":"M Sharifi","year":"2015","unstructured":"Sharifi M, Bay C, Vajo Z, Freeman W, Sharifi M, Schwartz F. New oral anticoagulants in the treatment of heparin-induced thrombocytopenia. Thromb Res. 2015;135(4):607\u20139.","journal-title":"Thromb Res"},{"issue":"12","key":"3811_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/ccr3.411","volume":"3","author":"PB Larsen","year":"2015","unstructured":"Larsen PB, J\u00f8rgensen M, Friis-Hansen L, Ingeberg S. Apixaban used for the management of heparin-induced thrombocytopenia in a 72-year-old woman with lung cancer. Clin Case Rep. 2015;3(12):987\u20139.","journal-title":"Clin Case Rep"},{"issue":"3","key":"3811_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11239-016-1458-9","volume":"43","author":"G Delgado-Garc\u00eda","year":"2017","unstructured":"Delgado-Garc\u00eda G, Monreal-Robles R. Acute apixaban treatment of heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2017;43(3):289\u201390.","journal-title":"J Thromb Thrombolysis"},{"issue":"9","key":"3811_CR25","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.mayocp.2013.06.013","volume":"88","author":"FJ Anniccherico","year":"2013","unstructured":"Anniccherico FJ, Alonso JL. Dabigatran for heparin-induced thrombocytopenia. Mayo Clin Proc. 2013;88(9):1036.","journal-title":"Mayo Clin Proc"},{"key":"3811_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/985253","volume":"2015","author":"E Noel","year":"2015","unstructured":"Noel E, Abbas N, Skaradinskiy Y, Schreiber Z. Heparin-induced thrombocytopenia in a patient with essential thrombocythemia: a case based update. Case Rep Hematol. 2015;2015:1\u20135.","journal-title":"Case Rep Hematol"},{"issue":"22","key":"3811_CR27","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","volume":"2","author":"A Cuker","year":"2018","unstructured":"Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2(22):3360\u201392.","journal-title":"Blood Adv"},{"issue":"5","key":"3811_CR28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1600-0609.2008.01035.x","volume":"80","author":"F Altuntas","year":"2008","unstructured":"Altuntas F, Matevosyan K, Burner J, Shen YM, Sarode R. Higher optical density of an antigen assay predicts thrombosis in patients with heparin-induced thrombocytopenia. Eur J Haematol. 2008;80(5):429\u201335.","journal-title":"Eur J Haematol"},{"issue":"1","key":"3811_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.amjmed.2011.06.025","volume":"125","author":"S Baroletti","year":"2012","unstructured":"Baroletti S, Hurwitz S, Conti NAS, Fanikos J, Piazza G, Goldhaber SZ. Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels. Am J Med. 2012;125(1):44\u20139.","journal-title":"Am J Med"},{"issue":"11","key":"3811_CR30","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1182\/blood.V84.11.3691.bloodjournal84113691","volume":"84","author":"T Warkentin","year":"1994","unstructured":"Warkentin T, Hayward C, Boshkov L, Santos A, Sheppard J, Bode A, et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood. 1994;84(11):3691\u20139.","journal-title":"Blood"},{"issue":"6","key":"3811_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/jth.12905","volume":"13","author":"M Arman","year":"2015","unstructured":"Arman M, Krauel K. Human platelet IgG Fc receptor Fc\u03b3RIIA in immunity and thrombosis. J Thromb Haemost. 2015;13(6):893\u2013908.","journal-title":"J Thromb Haemost"},{"issue":"23","key":"3811_CR32","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1182\/blood-2010-03-276964","volume":"116","author":"L Rauova","year":"2010","unstructured":"Rauova L, Hirsch JD, Greene TK, Zhai L, Hayes VM, Kowalska MA, et al. Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia. Blood. 2010;116(23):5021\u201331.","journal-title":"Blood"},{"issue":"22","key":"3811_CR33","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1182\/blood-2011-06-359430","volume":"119","author":"RS Kasthuri","year":"2012","unstructured":"Kasthuri RS, Glover SL, Jonas W, McEachron T, Pawlinski R, Arepally GM, et al. PF4\/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of Fc\u03b3RI. Blood. 2012;119(22):5285\u201393.","journal-title":"Blood"},{"issue":"10","key":"3811_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM198703053161004","volume":"316","author":"DB Cines","year":"1987","unstructured":"Cines DB, Tomaski A, Tannenbaum S. Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med. 1987;316(10):581\u20139.","journal-title":"N Engl J Med"},{"issue":"07","key":"3811_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1160\/TH13-08-0634","volume":"112","author":"S Brandt","year":"2014","unstructured":"Brandt S, Krauel K, Gottschalk KE, Renn\u00e9 T, Helm CA, Greinacher A, et al. Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity. Thromb Haemost. 2014;112(07):53\u201364.","journal-title":"Thromb Haemost"},{"issue":"9","key":"3811_CR36","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1182\/blood.V92.9.3250","volume":"92","author":"L Ziporen","year":"1998","unstructured":"Ziporen L, Li ZQ, Park KS, Sabnekar P, Liu WY, Arepally G, et al. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia. Blood. 1998;92(9):3250\u20139.","journal-title":"Blood"},{"issue":"17","key":"3811_CR37","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2013-01-477091","volume":"121","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Yu M, Podd A, Yuan L, Newman DK, Wen R, et al. Critical role for mouse marginal zone B cells in PF4\/heparin antibody production. Blood. 2013;121(17):3484\u201392.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03811-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03811-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03811-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:30:51Z","timestamp":1724931051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03811-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3811"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03811-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"assertion":[{"value":"10 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Supplementary file was missing from this article and has now been uploaded.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflict of interest noted for any authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}